These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 1375811)
21. Prospective evaluation of prenatal maternal serum screening for trisomy 18. Yankowitz J; Fulton A; Williamson R; Grant SS; Budelier WT Am J Obstet Gynecol; 1998 Mar; 178(3):446-50. PubMed ID: 9539506 [TBL] [Abstract][Full Text] [Related]
22. Second-trimester maternal serum screening for Down's syndrome: free beta-human chorionic gonadotrophin (HCG) and alpha-fetoprotein, with or without unconjugated oestriol, compared with total HCG, alpha-fetoprotein and unconjugated oestriol. Extermann P; Bischof P; Marguerat P; Mermillod B Hum Reprod; 1998 Jan; 13(1):220-3. PubMed ID: 9512261 [TBL] [Abstract][Full Text] [Related]
23. Maternal serum triple analyte screening in pregnancy. Graves JC; Miller KE; Sellers AD Am Fam Physician; 2002 Mar; 65(5):915-20. PubMed ID: 11898965 [TBL] [Abstract][Full Text] [Related]
24. Maternal serum analyte levels after first-trimester multifetal pregnancy reduction. Shulman LP; Phillips OP; Cervetti TA Am J Obstet Gynecol; 1996 Mar; 174(3):1072-4. PubMed ID: 8633639 [TBL] [Abstract][Full Text] [Related]
25. Second-trimester maternal serum alpha-fetoprotein, unconjugated estriol, and hCG levels in pregnancies with ventral wall defects. Saller DN; Canick JA; Palomaki GE; Knight GJ; Haddow JE Obstet Gynecol; 1994 Nov; 84(5):852-5. PubMed ID: 7524003 [TBL] [Abstract][Full Text] [Related]
26. Significance of a false-positive trisomy 18 multiple-marker screening test. Wenstrom KD; Owen J; Brumfield CG; Davis RO; Dubard M; Garcia T Obstet Gynecol; 1997 Dec; 90(6):938-42. PubMed ID: 9397107 [TBL] [Abstract][Full Text] [Related]
27. Multiple-marker screening in pregnancies with hydropic and nonhydropic Turner syndrome. Saller DN; Canick JA; Schwartz S; Blitzer MG Am J Obstet Gynecol; 1992 Oct; 167(4 Pt 1):1021-4. PubMed ID: 1384332 [TBL] [Abstract][Full Text] [Related]
28. [Significance of the maternal levels of serum alpha-fetoprotein, human chorionic gonadotropin and unconjugated estriol in various congenital developmental defects in pregnancy trimester II]. Kostiuk EV; Zolotukhina TV; Kuznetsov MI Genetika; 1992 Sep; 28(9):158-62. PubMed ID: 1282117 [TBL] [Abstract][Full Text] [Related]
30. Association between second-trimester isolated high maternal serum maternal serum human chorionic gonadotropin levels and obstetric complications in singleton and twin pregnancies. Lepage N; Chitayat D; Kingdom J; Huang T Am J Obstet Gynecol; 2003 May; 188(5):1354-9. PubMed ID: 12748511 [TBL] [Abstract][Full Text] [Related]
31. Maternal serum-integrated screening for trisomy 18 using both first- and second-trimester markers. Palomaki GE; Neveux LM; Knight GJ; Haddow JE Prenat Diagn; 2003 Mar; 23(3):243-7. PubMed ID: 12627428 [TBL] [Abstract][Full Text] [Related]
32. Maternal serum screening for fetal trisomy 18: a comparison of fixed cutoff and patient-specific risk protocols. Benn PA; Leo MV; Rodis JF; Beazoglou T; Collins R; Horne D Obstet Gynecol; 1999 May; 93(5 Pt 1):707-11. PubMed ID: 10912972 [TBL] [Abstract][Full Text] [Related]
33. Screening for pre-eclampsia by using maternal serum inhibin A, activin A, human chorionic gonadotropin, unconjugated estriol, and alpha-fetoprotein levels and uterine artery Doppler in the second trimester of pregnancy. Ay E; Kavak ZN; Elter K; Gokaslan H; Pekin T Aust N Z J Obstet Gynaecol; 2005 Aug; 45(4):283-8. PubMed ID: 16029293 [TBL] [Abstract][Full Text] [Related]
34. Human chorionic gonadotrophin and trisomy 18. Barkai G; Chaki R; Sochat M; Goldman B Am J Med Genet; 1991 Oct; 41(1):52-3. PubMed ID: 1719814 [TBL] [Abstract][Full Text] [Related]
35. Replacing Alpha-Fetoprotein With Alpha-Fetoprotein-L3 Increases the Sensitivity of Prenatal Screening for Trisomy 21. Huai L; Leng J; Ma S; Huang F; Shen J; Ding Y Am J Ther; 2016; 23(6):e1754-e1757. PubMed ID: 26938756 [TBL] [Abstract][Full Text] [Related]
36. Maternal serum screening for Down's syndrome, open neural tube defects and trisomy 18. Akbas SH; Ozben T; Alper O; Ugur A; Yücel G; Lüleci G Clin Chem Lab Med; 2001 Jun; 39(6):487-90. PubMed ID: 11506458 [TBL] [Abstract][Full Text] [Related]
37. 'Dual positivity' for neural tube defects and down syndrome at maternal serum screening: gestational outcome. Zanini R; Tarantini M; Cerri V; Jacobello C; Bellotti D; Lancetti S; Scalchi S; Groli C; Bianchi UA Fetal Diagn Ther; 1998; 13(2):106-10. PubMed ID: 9650657 [TBL] [Abstract][Full Text] [Related]
38. Preliminary estimate for the second-trimester maternal serum screening detection rate of the 45,X karyotype using alpha-fetoprotein, unconjugated estriol and human chorionic gonadotropin. Benn PA; Ying J J Matern Fetal Neonatal Med; 2004 Mar; 15(3):160-6. PubMed ID: 15280141 [TBL] [Abstract][Full Text] [Related]
39. Alpha-fetoprotein, free beta-human chorionic gonadotropin, and dimeric inhibin A produce the best results in a three-analyte, multiple-marker screening test for fetal Down syndrome. Wenstrom KD; Owen J; Chu DC; Boots L Am J Obstet Gynecol; 1997 Nov; 177(5):987-91. PubMed ID: 9396880 [TBL] [Abstract][Full Text] [Related]
40. 2nd-trimester maternal serum human chorionic gonadotropin and alpha-fetoprotein levels in male and female fetuses with Down syndrome. Lehavi O; Aizenstein O; Evans MI; Yaron Y Fetal Diagn Ther; 2005; 20(3):235-8. PubMed ID: 15824504 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]